ICYMI: Congress Calls For Increased Oversight and Transparency of 340B Program
July 24, 2017
The House Energy & Commerce Subcommittee on Oversight and Investigations held a hearing last Tuesday to examine the Health Resources and Services Administration’s (HRSA) oversight of the 340B drug pricing program.
AIR340B Gains Five New Members
July 19, 2017
The Alliance for Integrity and Reform of 340B (AIR340B) announced the addition of five new members to the coalition: Citizens Against Government Waste (GAGW), Genentech, Medical Oncology Association of Southern California Inc. (MOASC), the National Medical Association (NMA), and the National Council of Asian Pacific Islander Physicians). These organizations join the diverse group of health care stakeholders that have come together to advance reforms that strengthen and sustain 340B.
The Time for Strengthening the 340B Program is Now
March 9, 2017
The Alliance for Integrity and Reform of 340B (AIR340B) today delivered a letter to Members of Congress urging them to take action and increase oversight of the 340B program.
New Study Finds Unprecedented 340B Program Growth To Continue
December 6, 2016
A new study released today by the Alliance for Integrity and Reform of 340B (AIR 340B) projects the 340B Drug Pricing Program will continue to expand at an unprecedented rate through 2021, by which time it is expected to exceed $23 billion in total purchases at the 340B price. This rapid expansion would see 340B purchases surpass current Medicare Part B drug reimbursement purchases over the next five years.
Report: Increasing Number of 340B Hospitals Provide Minimal Charity Care
May 12, 2016
The Alliance for Integrity and Reform of 340B (AIR340B) today released a report using public data analyzed by Avalere Health that found a dramatic decline in charity care provided by 340B hospitals in 2014—the first year of the Affordable Care Act’s coverage expansion. Specifically, more than one-third (37 percent) of 340B hospitals provided charity care representing less than 1 percent of total patient costs in 2014. This is notably higher than the 24 percent of hospitals with that low level of charity care in 2011.
Report Finds 340B Hospitals Have Low Compliance with ACA Charity Care Requirements
April 25, 2016
The Alliance for Integrity and Reform of 340B (AIR340B) today released a report from the Berkeley Research Group (BRG) examining hospitals’ compliance with the Affordable Care Act’s (ACA) charity care requirements. The report, which expands on a study published in the New England Journal of Medicine (NEJM) last year, found large numbers of both 340B and non-340B hospitals not complying with key ACA protections for low-income patients.
Fact Sheet Compares, Examines Distribution of Physician Administered Drugs Among 340B and Non-340B Hospitals
February 2, 2016
A fact sheet released today by the Alliance for Integrity and Reform of 340B (AIR340B) uses research from the Berkeley Research Group (BRG) on Medicare Part B hospital outpatient reimbursements. The research found 340B hospitals account for the majority of Part B reimbursement compared to non-340B hospitals and 340B hospitals have been driving most of the growth in Part B reimbursement over time.
340B Hospitals Are More Likely to Acquire Physician Practices, Study Suggests
June 8, 2015
An analysis released today by Avalere Health and funded by the Alliance for Integrity and Reform of 340B (AIR 340B) found hospitals participating in the 340B Drug Pricing Program were more likely to acquire independent physician practices than non-340B hospitals.